420 related articles for article (PubMed ID: 12206515)
1. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
Reinholz MM; Iturria SJ; Ingle JN; Roche PC
Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
[TBL] [Abstract][Full Text] [Related]
2. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
3. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells.
Jaatinen R; Bondestam J; Raivio T; Hildén K; Dunkel L; Groome N; Ritvos O
J Clin Endocrinol Metab; 2002 Mar; 87(3):1254-61. PubMed ID: 11889196
[TBL] [Abstract][Full Text] [Related]
4. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.
de Jong DS; van Zoelen EJ; Bauerschmidt S; Olijve W; Steegenga WT
J Bone Miner Res; 2002 Dec; 17(12):2119-29. PubMed ID: 12469906
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas.
Alarmo EL; Korhonen T; Kuukasjärvi T; Huhtala H; Holli K; Kallioniemi A
Ann Oncol; 2008 Feb; 19(2):308-14. PubMed ID: 17895257
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue.
Reinholz MM; An MW; Johnsen SA; Subramaniam M; Suman VJ; Ingle JN; Roche PC; Spelsberg TC
Breast Cancer Res Treat; 2004 Jul; 86(1):75-88. PubMed ID: 15218362
[TBL] [Abstract][Full Text] [Related]
9. Activin, inhibin and the human breast.
Reis FM; Luisi S; Carneiro MM; Cobellis L; Federico M; Camargos AF; Petraglia F
Mol Cell Endocrinol; 2004 Oct; 225(1-2):77-82. PubMed ID: 15451571
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
[TBL] [Abstract][Full Text] [Related]
11. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
12. Expression of bone associated macromolecules by gingival and periodontal ligament fibroblasts.
Ivanovski S; Li H; Haase HR; Bartold PM
J Periodontal Res; 2001 Jun; 36(3):131-41. PubMed ID: 11453111
[TBL] [Abstract][Full Text] [Related]
13. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
[TBL] [Abstract][Full Text] [Related]
14. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.
Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of inhibin A and activin A subunit gene loci in epithelial ovarian cancer.
Depasquale S; Lambert-Messerlian G; Quddus MR; Campbell I; Steinhoff M; Gajewski W; Granai C; Tantravahi U
Int J Gynecol Cancer; 2002; 12(5):443-7. PubMed ID: 12366660
[TBL] [Abstract][Full Text] [Related]
16. Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status.
Wang-Rodriguez J; Urquidi V; Rivard A; Goodison S
Breast Cancer Res; 2003; 5(5):R136-43. PubMed ID: 12927044
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
18. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.
Basu M; Bhattacharya R; Ray U; Mukhopadhyay S; Chatterjee U; Roy SS
Mol Cancer; 2015 Aug; 14():162. PubMed ID: 26298390
[TBL] [Abstract][Full Text] [Related]
19. Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
Kayed H; Kleeff J; Keleg S; Jiang X; Penzel R; Giese T; Zentgraf H; Büchler MW; Korc M; Friess H
Int J Oncol; 2006 Nov; 29(5):1139-48. PubMed ID: 17016645
[TBL] [Abstract][Full Text] [Related]
20. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
